Global Kidney Cancer Drug Sales Market Report Forecast 2017-2021

May 2017 | 135 pages | ID: G0302A1E1BEEN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 KIDNEY CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Classification of Kidney Cancer Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Kidney Cancer Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Kidney Cancer Drug Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Kidney Cancer Drug (2012-2021)
  1.5.1 Global Kidney Cancer Drug Sales and Growth Rate (2012-2021)
  1.5.2 Global Kidney Cancer Drug Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON KIDNEY CANCER DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

3.1 Kidney Cancer Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Kidney Cancer Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Kidney Cancer Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL KIDNEY CANCER DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Kidney Cancer Drug Market Competition by Manufacturers
  5.1.1 Global Kidney Cancer Drug Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Kidney Cancer Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Kidney Cancer Drug (Volume and Value) by Type
  5.5.1 Global Kidney Cancer Drug Sales and Market Share by Type (2012-2017)
  5.5.2 Global Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Kidney Cancer Drug (Volume and Value) by Regions
  5.3.1 Global Kidney Cancer Drug Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Kidney Cancer Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Kidney Cancer Drug (Volume) by Application

6 UNITED STATES KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 United States Kidney Cancer Drug Sales and Value (2012-2017)
  6.1.1 United States Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  6.1.2 United States Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  6.1.3 United States Kidney Cancer Drug Sales Price Trend (2012-2017)
6.2 United States Kidney Cancer Drug Sales and Market Share by Manufacturers
6.3 United States Kidney Cancer Drug Sales and Market Share by Type
6.4 United States Kidney Cancer Drug Sales and Market Share by Application

7 CHINA KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 China Kidney Cancer Drug Sales and Value (2012-2017)
  7.1.1 China Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  7.1.2 China Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  7.1.3 China Kidney Cancer Drug Sales Price Trend (2012-2017)
7.2 China Kidney Cancer Drug Sales and Market Share by Manufacturers
7.3 China Kidney Cancer Drug Sales and Market Share by Type
7.4 China Kidney Cancer Drug Sales and Market Share by Application

8 EUROPE KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Kidney Cancer Drug Sales and Value (2012-2017)
  8.1.1 Europe Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  8.1.2 Europe Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Kidney Cancer Drug Sales Price Trend (2012-2017)
8.2 Europe Kidney Cancer Drug Sales and Market Share by Manufacturers
8.3 Europe Kidney Cancer Drug Sales and Market Share by Type
8.4 Europe Kidney Cancer Drug Sales and Market Share by Application

9 JAPAN KIDNEY CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Kidney Cancer Drug Sales and Value (2012-2017)
  9.1.1 Japan Kidney Cancer Drug Sales and Growth Rate (2012-2017)
  9.1.2 Japan Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Kidney Cancer Drug Sales Price Trend (2012-2017)
9.2 Japan Kidney Cancer Drug Sales and Market Share by Manufacturers
9.3 Japan Kidney Cancer Drug Sales and Market Share by Type
9.4 Japan Kidney Cancer Drug Sales and Market Share by Application

10 GLOBAL KIDNEY CANCER DRUG MANUFACTURERS ANALYSIS

10.1 Bayer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 F. Hoffmann-La Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 GlaxoSmithKline
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Novartis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Pfizer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Abbott Laboratories
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Active Biotech
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Amgen
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Argos Therapeutics
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL KIDNEY CANCER DRUG MARKET FORECAST (2017-2021)

13.1 Global Kidney Cancer Drug Sales, Revenue Forecast (2017-2021)
13.2 Global Kidney Cancer Drug Sales Forecast by Regions (2017-2021)
13.3 Global Kidney Cancer Drug Sales Forecast by Type (2017-2021)
13.4 Global Kidney Cancer Drug Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Table Classification of Kidney Cancer Drug
Figure Global Sales Market Share of Kidney Cancer Drug by Type in 2015
Table Applications of Kidney Cancer Drug
Figure Global Sales Market Share of Kidney Cancer Drug by Application in 2015
Figure United States Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure China Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Japan Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Figure Global Kidney Cancer Drug Sales and Growth Rate (2012-2021)
Figure Global Kidney Cancer Drug Revenue and Growth Rate (2012-2021)
Table Global Kidney Cancer Drug Sales of Key Manufacturers (2012-2017)
Table Global Kidney Cancer Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers
Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers
Table Global Kidney Cancer Drug Revenue by Manufacturers (2012-2017)
Table Global Kidney Cancer Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table Global Kidney Cancer Drug Sales and Market Share by Type (2012-2017)
Table Global Kidney Cancer Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Kidney Cancer Drug by Type (2012-2017)
Figure Global Kidney Cancer Drug Sales Growth Rate by Type (2012-2017)
Table Global Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
Table Global Kidney Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Kidney Cancer Drug by Type (2012-2017)
Figure Global Kidney Cancer Drug Revenue Growth Rate by Type (2012-2017)
Table Global Kidney Cancer Drug Sales and Market Share by Regions (2012-2017)
Table Global Kidney Cancer Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Kidney Cancer Drug by Regions (2012-2017)
Figure Global Kidney Cancer Drug Sales Growth Rate by Regions (2012-2017)
Table Global Kidney Cancer Drug Revenue and Market Share by Regions (2012-2017)
Table Global Kidney Cancer Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Kidney Cancer Drug by Regions (2012-2017)
Figure Global Kidney Cancer Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Kidney Cancer Drug Sales and Market Share by Application (2012-2017)
Table Global Kidney Cancer Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Kidney Cancer Drug by Application (2012-2017)
Figure Global Kidney Cancer Drug Sales Growth Rate by Application (2012-2017)
Figure United States Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure United States Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure United States Kidney Cancer Drug Sales Price Trend (2012-2017)
Table United States Kidney Cancer Drug Sales by Manufacturers (2012-2017)
Table United States Kidney Cancer Drug Market Share by Manufacturers (2012-2017)
Table United States Kidney Cancer Drug Sales by Type (2012-2017)
Table United States Kidney Cancer Drug Market Share by Type (2012-2017)
Table United States Kidney Cancer Drug Sales by Application (2012-2017)
Table United States Kidney Cancer Drug Market Share by Application (2012-2017)
Figure China Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure China Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure China Kidney Cancer Drug Sales Price Trend (2012-2017)
Table China Kidney Cancer Drug Sales by Manufacturers (2012-2017)
Table China Kidney Cancer Drug Market Share by Manufacturers (2012-2017)
Table China Kidney Cancer Drug Sales by Type (2012-2017)
Table China Kidney Cancer Drug Market Share by Type (2012-2017)
Table China Kidney Cancer Drug Sales by Application (2012-2017)
Table China Kidney Cancer Drug Market Share by Application (2012-2017)
Figure Europe Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Europe Kidney Cancer Drug Sales Price Trend (2012-2017)
Table Europe Kidney Cancer Drug Sales by Manufacturers (2012-2017)
Table Europe Kidney Cancer Drug Market Share by Manufacturers (2012-2017)
Table Europe Kidney Cancer Drug Sales by Type (2012-2017)
Table Europe Kidney Cancer Drug Market Share by Type (2012-2017)
Table Europe Kidney Cancer Drug Sales by Application (2012-2017)
Table Europe Kidney Cancer Drug Market Share by Application (2012-2017)
Figure Japan Kidney Cancer Drug Sales and Growth Rate (2012-2017)
Figure Japan Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Japan Kidney Cancer Drug Sales Price Trend (2012-2017)
Table Japan Kidney Cancer Drug Sales by Manufacturers (2012-2017)
Table Japan Kidney Cancer Drug Market Share by Manufacturers (2012-2017)
Table Japan Kidney Cancer Drug Sales by Type (2012-2017)
Table Japan Kidney Cancer Drug Market Share by Type (2012-2017)
Table Japan Kidney Cancer Drug Sales by Application (2012-2017)
Table Japan Kidney Cancer Drug Market Share by Application (2012-2017)
Table Bayer Basic Information List
Table Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Kidney Cancer Drug Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Kidney Cancer Drug Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Kidney Cancer Drug Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Kidney Cancer Drug Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Kidney Cancer Drug Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Kidney Cancer Drug Global Market Share (2012-2017)
Table Active Biotech Basic Information List
Table Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Active Biotech Kidney Cancer Drug Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Kidney Cancer Drug Global Market Share (2012-2017)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Argos Therapeutics Kidney Cancer Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Global Kidney Cancer Drug Sales and Growth Rate Forecast (2017-2021)
Figure Global Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Kidney Cancer Drug Sales Forecast by Regions (2017-2021)
Table Global Kidney Cancer Drug Sales Forecast by Type (2017-2021)
Table Global Kidney Cancer Drug Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics
ArQule
AVEO Pharmaceuticals
Bionomics
Bristol-Myers Squibb
Cerulean Pharma
Exelixis
Genentech
immatics biotechnologies
Immunicum
Ono Pharmaceutical
Onyx Therapeutics
Oxford BioMedica
Prometheus Laboratories
Seattle Genetics
Taiwan Liposome
TRACON Pharmaceuticals
Wilex